All-trans retinoic acid suppresses exocrine differentiation and branching morphogenesis in the embryonic pancreas

Chia-Ning Shen1, Anita Marguerie, Chiao-Yun Chien

  • 1Centre for Regenerative Medicine, Department of Biology and Biochemistry, University of Bath, Bath BA2 7AY, UK.

Insights

Retinoic acid (RA) inhibits mouse embryonic pancreas development by suppressing branching and exocrine differentiation while promoting premature endocrine cell formation. Fibroblast growth factor (FGF)-10 partially rescues these effects via FGF receptor 2-IIIb.

Area of Science:

  • Developmental biology
  • Endocrinology
  • Molecular biology

Background:

  • Retinoic acid (RA) signaling is crucial for early pancreatic development in amphibians but its role in mammalian pancreatic differentiation remains unclear.
  • Understanding RA's impact on mammalian pancreas development is vital for regenerative medicine and treating pancreatic diseases.

Purpose of the Study:

  • To investigate the effects of all-trans retinoic acid (atRA) on mouse embryonic pancreatic differentiation.
  • To elucidate the underlying mechanisms of atRA-induced changes in pancreatic development.
  • To explore the potential role of fibroblast growth factor (FGF)-10 in modulating these effects.

Main Methods:

  • Organotypic culture of mouse embryonic pancreas with atRA treatment.
  • Analysis of branching morphogenesis and exocrine/endocrine cell differentiation markers.
  • Investigation of gene expression (Pdx1) and apoptosis.
  • FGF-10 treatment and assessment in wild-type and FGF receptor mutant mice.

Main Results:

  • atRA suppressed branching morphogenesis and exocrine differentiation.
  • Premature formation of endocrine cell clusters was observed, linked to early Pdx1 expression.
  • RA's suppressive effects on exocrine differentiation involved laminin up-regulation and enhanced apoptosis.
  • FGF-10 partially rescued apoptosis and exocrine differentiation, mediated through FGF receptor 2-IIIb.

Conclusions:

  • Retinoic acid significantly impacts mouse embryonic pancreatic differentiation, inhibiting key developmental processes.
  • RA's effects are mediated through modulation of Pdx1 expression, extracellular matrix components, and apoptosis.
  • FGF-10 acts through FGF receptor 2-IIIb to counteract some of RA's inhibitory effects on pancreatic development.